HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of "Moderate Buy" from Analysts

Key Points

• Analysts have assigned HealthEquity an average rating of "Moderate Buy" from 15 brokerages (12 buys, 1 strong buy, 1 hold, 1 sell) with an average 12‑month price objective of about $111.79.
• HealthEquity recently reported an EPS beat of $0.95 vs. $0.90 and revenue of $334.6M (+7.3% YoY) versus $332.5M expected, while shares trade around $82.45 with a $6.97B market cap, P/E of 33.5 and roughly 99.55% institutional ownership.

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fifteen brokerages that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, twelve have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $111.7857.

HQY has been the subject of several research analyst reports. KeyCorp raised their price objective on HealthEquity from $120.00 to $125.00 and gave the stock an "overweight" rating in a research note on Thursday, January 8th. Jefferies Financial Group set a $108.00 price objective on HealthEquity in a research note on Thursday, February 19th. JPMorgan Chase & Co. reduced their price objective on HealthEquity from $129.00 to $123.00 and set an "overweight" rating for the company in a research note on Wednesday, March 18th. The Goldman Sachs Group cut HealthEquity from a "neutral" rating to a "sell" rating and set a $89.00 price objective for the company. in a research note on Friday, January 9th. Finally, Barrington Research reduced their price objective on HealthEquity from $125.00 to $110.00 and set an "outperform" rating for the company in a research note on Wednesday, March 18th.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Simplify Asset Management Inc. acquired a new stake in HealthEquity in the third quarter valued at approximately $1,498,000. Capricorn Fund Managers Ltd acquired a new stake in HealthEquity in the fourth quarter valued at approximately $6,926,000. 12th Street Asset Management Company LLC grew its holdings in HealthEquity by 114.4% in the third quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company's stock valued at $25,784,000 after purchasing an additional 145,151 shares during the period. Oppenheimer Asset Management Inc. grew its holdings in HealthEquity by 45.5% in the third quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company's stock valued at $14,741,000 after purchasing an additional 48,621 shares during the period. Finally, Bessemer Group Inc. grew its holdings in HealthEquity by 21.3% in the third quarter. Bessemer Group Inc. now owns 349,342 shares of the company's stock valued at $33,108,000 after purchasing an additional 61,317 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Trading Up 6.0%

Shares of NASDAQ:HQY opened at $82.45 on Friday. HealthEquity has a 52-week low of $72.76 and a 52-week high of $116.65. The stock has a market cap of $6.97 billion, a price-to-earnings ratio of 33.52, a PEG ratio of 1.41 and a beta of 0.26. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45. The business has a 50-day moving average price of $80.44 and a 200-day moving average price of $88.29.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.05. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The firm had revenue of $334.59 million during the quarter, compared to analysts' expectations of $332.48 million. HealthEquity's revenue was up 7.3% on a year-over-year basis. Equities analysts predict that HealthEquity will post 3.84 EPS for the current year.

About HealthEquity

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.